Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
Pfizer (PFE) Stock Price & Analysis
27,855 Followers
PFE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.20 - $38.80
Previous Close$25.4
Volume41.67M
Average Volume (3M)42.29M
Market Cap
$143.43B
Enterprise Value$203.36B
Total Cash (Recent Filing)$12.69B
Total Debt (Recent Filing)$72.35B
Price to Earnings (P/E)67.6
Beta0.49
Next Earnings
May 01, 2024EPS Estimate
$0.53Next Dividend Ex-Date
May 09, 2024Dividend Yield6.53%
Share Statistics
EPS (TTM)0.36
Shares Outstanding5,646,778,425
10 Day Avg. Volume36,073,379
30 Day Avg. Volume42,294,515
Standard Deviation0.08
R-Squared0.17
Alpha-0.00724
Financial Highlights & Ratios
Price to Book (P/B)-3.28
Price to Sales (P/S)2.45
Price to Cash Flow (P/CF)6.80
P/FCF Ratio7.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.48
Enterprise Value/Gross Profit6.06
Enterprise Value/Ebitda39.82
Forecast
1Y Price Target
$31.70Price Target Upside23.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Pfizer News
Bulls Say, Bears Say
Bulls Say
Pipeline AdvancementPfizer's next-generation pneumococcal vaccine aims to cover more serotypes than Prevnar20, using new conjugation chemistry, showcasing innovation in its vaccine development.
Product SalesPaxlovid is positioned for upside with strong results expected and potential to exceed future guidance based on current trends.
Strategic GrowthThe integration of Seagen is expected to drive significant growth, with Pfizer projecting $10 billion in sales by 2030, indicating a robust growth strategy.
Bears Say
Drug DevelopmentA setback in the development of an oral GLP-1 drug for weight loss could delay Pfizer's entry into the competitive market for weight-loss therapies.
Financial HealthPfizer's balance sheet has weakened, with a significant increase in the debt/equity ratio and total debt nearly doubling from the previous year.
Financial PerformanceProducts such as Nurtec, Prevnar, and Ibrance may disappoint with sales missing consensus estimates.
---
Ownership Overview
0.26% Insiders
21.76% Mutual Funds
23.15% Other Institutional Investors
54.83% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PFE FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $25.20 and its highest was $38.80 in the past 12 months.
What is Pfizer’s market cap?
Currently, no data Available
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is May 01, 2024 which is yesterday.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on Jan 30, 2024. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.158 by $0.258.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of $0.42 which represents an annual dividend yield of 6.53%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is $0.53.
How many shares outstanding does Pfizer have?
Pfizer has 5,646,778,300 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.158. Following the earnings report the stock price went down -1.674%.
Which hedge fund is a major shareholder of Pfizer?
Among the largest hedge funds holding Pfizer’s share is Diamond Hill Capital Management Inc. It holds Pfizer’s shares valued at 340M.
---
Pfizer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.70 (23.63% Upside)
$31.70 (23.63% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 76%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 6.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.4%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.67%
12-Months-Change
Fundamentals
Return on Equity
2.31%
Trailing 12-Months
Asset Growth
14.86%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
---
PFE Company Deck
---
PFE Earnings Call
Q4 2024
0:00 / 0:00
---
PFE Revenue Breakdown
52.29% Primary Care
25.59% Specialty Care
19.88% Oncology
2.24% BUSINESS INNOVATION
---
PFE Stock 12 Months Forecast
Average Price Target
$31.70
▲(23.63% Upside)
Technical Analysis
Best Analysts Covering PFE
1 Year
1 Year Success Rate
25/34 ratings generated profit
1 Year Average Return
+5.25%
initiated a buy rating 2 months ago
Copying Vamil Divan's trades and holding each position for 1 Year would result in 73.53% of your transactions generating a profit, with an average return of +5.25% per trade.
---